The future of the global oligonucleotide synthesis market looks promising with opportunities in hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, CROs and CMOs, and academic research institutes. The global oligonucleotide synthesis market is expected to reach an estimated $15.8 billion by 2028 with a CAGR of 16.1% from 2023 to 2028. The major drivers for this market are increasing government funding and research investments within the pharmaceutical and biotechnology sectors, rising utilization of synthesized oligonucleotides in molecular diagnostics and clinical applications, and rising incidence of cancer and genetic disorders globally.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown here.
Answer: The global oligonucleotide synthesis market is expected to reach an estimated $15.8 billion by 2028.
Q.2 What is the growth forecast for oligonucleotide synthesis market?
Answer: The global oligonucleotide synthesis market is expected to grow with a CAGR of 16.1% from 2023 to 2028.
Q.3 What are the major drivers influencing the growth of the oligonucleotide synthesis market?
Answer: The major drivers for this market are increasing government funding and research investments within the pharmaceutical and biotechnology sectors, rising utilization of synthesized oligonucleotides in molecular diagnostics and clinical applications, and rising incidence of cancer and genetic disorders globally.
Q4. What are the major segments for oligonucleotide synthesis market?
Answer: The future of the global oligonucleotide synthesis market looks promising with opportunities in hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, CROs and CMOs, and academic research institutes.
Q5. Who are the key oligonucleotide synthesis companies?
Answer: Some of the key oligonucleotide synthesis companies are as follows:
Answer: The publisher forecasts that oligonucleotide will witness the highest growth over the forecast period due to the rising prevalence of genomic research endeavors, including gene expression analysis and genetic testing, along with the advent of biochips (DNA chips) enabling simultaneous analysis of various clinical samples.
Q7. In oligonucleotide synthesis market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to increasing incidence of chronic diseases and the substantial presence of numerous companies and research institutes in this region.
Q.8 Do we receive customization in this report?
Answer: Yes, the publisher provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the oligonucleotide synthesis market by product (oligonucleotides, equipment/synthesizer, reagents, services, purification, and modification), application (PCR primers, PCR assays and panels, sequencing, DNA microarrays, fluorescence in situ hybridization (FISH), antisense oligonucleotides, and others), end use industry (hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, CROs and CMOs, and academic research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown here.
Oligonucleotide Synthesis Market by Segment
The study includes a forecast for the global oligonucleotide synthesis market by product, application, end use industry, and region, as follows:Oligonucleotide Synthesis Market by Product (Shipment Analysis by Value from 2017 to 2028):
- Oligonucleotides
- Equipment/Synthesizer
- Reagents
- Services
- Purification
- Modification
Oligonucleotide Synthesis Market by Application (Shipment Analysis by Value from 2017 to 2028):
- PCR Primers
- PCR Assays and Panels
- Sequencing
- DNA Microarrays
- Fluorescence In Situ Hybridization (FISH)
- Antisense Oligonucleotides
- Others
Oligonucleotide Synthesis Market by End Use Industry (Shipment Analysis by Value from 2017 to 2028):
- Hospitals
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
- CROs and CMOs
- Academic Research Institutes
Oligonucleotide Synthesis Market by Region (Shipment Analysis by Value from 2017 to 2028):
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Oligonucleotide Synthesis Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, oligonucleotide synthesis companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the oligonucleotide synthesis companies profiled in this report include:- Thermo Fisher Scientific
- GE Healthcare
- Dharmacon
- Agilent Technologies
- Bio-synthesis
- Kaneka Eurogentec
- Integrated DNA Technologies
- BioAutomation
- Biolegio
- Twist Bioscience
Oligonucleotide Synthesis Market Insights
- The publisher that oligonucleotide will witness the highest growth over the forecast period due to the rising prevalence of genomic research endeavors, including gene expression analysis and genetic testing, along with the advent of biochips (DNA chips) enabling simultaneous analysis of various clinical samples
- Within this market, academic research institutes will remain the largest segment due to robust genomic research being conducted by universities and academic research institutes either in collaboration with private investors or with government support along with huge investments in the genomic research in developed countries
- North America will remain the largest region over the forecast period due to increasing incidence of chronic diseases and the substantial presence of numerous companies and research institutes in this region
Features of the Global Oligonucleotide Synthesis Market
- Market Size Estimates: Oligonucleotide synthesis market size estimation in terms of value ($B)
- Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions
- Segmentation Analysis: Oligonucleotide synthesis market size by various segments, such as by product, application, end use industry, and region in terms of value ($B)
- Regional Analysis: Oligonucleotide synthesis market breakdown by North America, Europe, Asia Pacific, and Rest of the World
- Growth Opportunities: Analysis of growth opportunities in different products, applications, end use industries, and regions for the Oligonucleotide Synthesis Market
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the oligonucleotide synthesis market
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model
FAQS
Q.1 What is the oligonucleotide synthesis market size?Answer: The global oligonucleotide synthesis market is expected to reach an estimated $15.8 billion by 2028.
Q.2 What is the growth forecast for oligonucleotide synthesis market?
Answer: The global oligonucleotide synthesis market is expected to grow with a CAGR of 16.1% from 2023 to 2028.
Q.3 What are the major drivers influencing the growth of the oligonucleotide synthesis market?
Answer: The major drivers for this market are increasing government funding and research investments within the pharmaceutical and biotechnology sectors, rising utilization of synthesized oligonucleotides in molecular diagnostics and clinical applications, and rising incidence of cancer and genetic disorders globally.
Q4. What are the major segments for oligonucleotide synthesis market?
Answer: The future of the global oligonucleotide synthesis market looks promising with opportunities in hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, CROs and CMOs, and academic research institutes.
Q5. Who are the key oligonucleotide synthesis companies?
Answer: Some of the key oligonucleotide synthesis companies are as follows:
- Thermo Fisher Scientific
- GE Healthcare
- Dharmacon
- Agilent Technologies
- Bio-Synthesis
- Kaneka Eurogentec
- Integrated DNA Technologies
- BioAutomation
- Biolegio
- Twist Bioscience
Answer: The publisher forecasts that oligonucleotide will witness the highest growth over the forecast period due to the rising prevalence of genomic research endeavors, including gene expression analysis and genetic testing, along with the advent of biochips (DNA chips) enabling simultaneous analysis of various clinical samples.
Q7. In oligonucleotide synthesis market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to increasing incidence of chronic diseases and the substantial presence of numerous companies and research institutes in this region.
Q.8 Do we receive customization in this report?
Answer: Yes, the publisher provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the oligonucleotide synthesis market by product (oligonucleotides, equipment/synthesizer, reagents, services, purification, and modification), application (PCR primers, PCR assays and panels, sequencing, DNA microarrays, fluorescence in situ hybridization (FISH), antisense oligonucleotides, and others), end use industry (hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, CROs and CMOs, and academic research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Global Oligonucleotide Synthesis Market: Market Dynamics
3. Market Trends and Forecast Analysis from 2017 to 2028
4. Market Trends and Forecast Analysis by Region from 2017 to 2028
5. Competitor Analysis
6. Growth Opportunities and Strategic Analysis
7. Company Profiles of Leading Players
Companies Mentioned
- Thermo Fisher Scientific
- GE Healthcare
- Dharmacon
- Agilent Technologies
- Bio-synthesis
- Kaneka Eurogentec
- Integrated DNA Technologies
- BioAutomation
- Biolegio
- Twist Bioscience
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
